
Telmisartan (40mg) + Chlorthalidone (12.5mg)
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Jekar-CT 40 Tablet is a combination antihypertensive medication containing Telmisartan 40mg and Chlorthalidone 12.5mg. Telmisartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, which leads to decreased blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes sodium and water excretion by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to a reduction in blood volume and peripheral resistance. The synergistic action of these two agents effectively manages hypertension, reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure. Jekar-CT 40 is indicated for the treatment of essential hypertension, particularly in patients who require combination therapy for optimal blood pressure control. It is contraindicated in patients with hypersensitivity to any component, severe renal or hepatic impairment, anuria, or electrolyte imbalances such as hypokalemia or hyponatremia. Common side effects may include dizziness, hypotension, electrolyte disturbances, and increased urination. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy to ensure safety and efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Jekar-CT 40 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Jekar-CT 40 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Jekar-CT 40 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Jekar-CT 40 Tablet may be needed. Please consult your doctor. Use of Jekar-CT 40 Tablet is not recommended in these patients.
Exercise Caution
Jekar-CT 40 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Jekar-CT 40 Tablet should be used with caution in patients with liver disease. Dose adjustment of Jekar-CT 40 Tablet may be needed. Please consult your doctor. Use of Jekar-CT 40 Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Jekar-CT 40 Tablet

Telmisartan (40mg) + Chlorthalidone (12.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
Jekar-CT 40 Tablet is a combination antihypertensive medication containing Telmisartan 40mg and Chlorthalidone 12.5mg. Telmisartan is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, which leads to decreased blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes sodium and water excretion by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to a reduction in blood volume and peripheral resistance. The synergistic action of these two agents effectively manages hypertension, reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure. Jekar-CT 40 is indicated for the treatment of essential hypertension, particularly in patients who require combination therapy for optimal blood pressure control. It is contraindicated in patients with hypersensitivity to any component, severe renal or hepatic impairment, anuria, or electrolyte imbalances such as hypokalemia or hyponatremia. Common side effects may include dizziness, hypotension, electrolyte disturbances, and increased urination. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy to ensure safety and efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Jekar-CT 40 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Jekar-CT 40 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Medical Advice
Jekar-CT 40 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Jekar-CT 40 Tablet may be needed. Please consult your doctor. Use of Jekar-CT 40 Tablet is not recommended in these patients.
Exercise Caution
Jekar-CT 40 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Jekar-CT 40 Tablet should be used with caution in patients with liver disease. Dose adjustment of Jekar-CT 40 Tablet may be needed. Please consult your doctor. Use of Jekar-CT 40 Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Jekar-CT 40 Tablet















